World Health Organization. WHO Coronavirus Disease (COVIS-19) Dashboard, https://covid19.who.int (2020, accessed 12 June 2020).
3.
ZhuN.ZhangD.WangWet al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med2020; 382: 727–733.doi:10.1056/NEJMoa2001017http://www.ncbi.nlm.nih.gov/pubmed/31978945
4.
ShiS.QinM.ShenBet al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. Epub ahead of print 25 Mar 2020. DOI: 10.1001/jamacardio.2020.0950. http://www.ncbi.nlm.nih.gov/pubmed/32211816
5.
FriedJA.RamasubbuK.BhattRet al. The variety of cardiovascular presentations of COVID-19. Circulation2020; 141: 1930–1936.doi:10.1161/CIRCULATIONAHA.120.047164http://www.ncbi.nlm.nih.gov/pubmed/32243205
6.
DanziGB.LoffiM.GaleazziGet al. Acute pulmonary embolism and COVID-19 pneumonia: a random association?Eur Heart J2020; 41: 1858.doi:10.1093/eurheartj/ehaa254http://www.ncbi.nlm.nih.gov/pubmed/32227120
ARDS Definition Task ForceRanieriVMRubenfeldGDet al. Acute respiratory distress syndrome: the Berlin definition. JAMA2012; 307: 2526–2533.doi:10.1001/jama.2012.5669http://www.ncbi.nlm.nih.gov/pubmed/22797452
9.
GattinoniL.ChiumelloD.RossiS. COVID-19 pneumonia: ARDS or not?Crit Care2020; 24: 154.doi:10.1186/s13054-020-02880-zhttp://www.ncbi.nlm.nih.gov/pubmed/32299472
10.
GattinoniL.ChiumelloD.CaironiPet al. COVID-19 pneumonia: different respiratory treatments for different phenotypes?Intensive Care Med2020; 46: 1099–1102.doi:10.1007/s00134-020-06033-232291463
11.
GattinoniL.PesentiA.AvalliLet al. Pressure-volume curve of total respiratory system in acute respiratory failure. Computed tomographic scan study. Am Rev Respir Dis1987; 136: 730–736.doi:10.1164/ajrccm/136.3.7303307572
12.
GattinoniL.CaironiP.CressoniMet al. Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med2006; 354: 1775–1786.doi:10.1056/NEJMoa052052http://www.ncbi.nlm.nih.gov/pubmed/16641394
13.
RamanathanK.AntogniniD.CombesAet al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med2020; 8: 518–526.doi:10.1016/S2213-2600(20)30121-1http://www.ncbi.nlm.nih.gov/pubmed/32203711
14.
ChenN.ZhouM.DongXet al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet2020; 395: 507–513.doi:10.1016/S0140-6736(20)30211-7http://www.ncbi.nlm.nih.gov/pubmed/32007143
15.
GrasselliG.ZangrilloA.ZanellaAet al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA2020; 323: 1574–1581.doi:10.1001/jama.2020.5394http://www.ncbi.nlm.nih.gov/pubmed/32250385
16.
LiX.GuoZ.LiBet al. Extracorporeal membrane oxygenation for coronavirus disease 2019 in Shanghai, China. ASAIO J2020; 66: 475–481.doi:10.1097/MAT.000000000000117232243266
17.
LiM.GuS-C.WuX-Jet al. Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation. Chin Med J2020; 133: 1115–1117.doi:10.1097/CM9.0000000000000778http://www.ncbi.nlm.nih.gov/pubmed/32118643
18.
HenryBM. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med2020; 8: e24.doi:10.1016/S2213-2600(20)30119-3http://www.ncbi.nlm.nih.gov/pubmed/32178774
19.
BartlettRH.OginoMT.BrodieDet al. Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J2020; 66: 472–474.doi:10.1097/MAT.000000000000117332243267
20.
RajagopalK.KellerSP.AkkantiBet al. Advanced pulmonary and cardiac support of COVID-19 patients: emerging recommendations from ASAIO-A “Living Working Document”. ASAIO J2020; 66: 588–598.doi:10.1097/MAT.000000000000118032358232
21.
World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020, https://apps.who.int/iris/rest/bitstreams/1272156/retrieve (2020, accessed 12 June 2020).
22.
AlhazzaniW.MøllerMH.ArabiYMet al. Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med2020; 46: 854–887.doi:10.1007/s00134-020-06022-5http://www.ncbi.nlm.nih.gov/pubmed/32222812
23.
Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza InvestigatorsDaviesAJonesDet al. Extracorporeal membrane oxygenation for 2009 Influenza A(H1N1) acute respiratory distress syndrome. JAMA2009; 302: 1888–1895.doi:10.1001/jama.2009.1535http://www.ncbi.nlm.nih.gov/pubmed/19822628
24.
ArabiYM.Al-OmariA.MandourahYet al. Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study. Crit Care Med2017; 45: 1683–1695.doi:10.1097/CCM.0000000000002621http://www.ncbi.nlm.nih.gov/pubmed/28787295
25.
BromanLM.Prahl WittbergL.WestlundCJet al. Pressure and flow properties of cannulae for extracorporeal membrane oxygenation I: return (arterial) cannulae. Perfusion2019; 34(1_suppl): 58–64.doi:10.1177/0267659119830521http://www.ncbi.nlm.nih.gov/pubmed/30966910
26.
FinaD.MatteucciM.JiritanoFet al. Extracorporeal membrane oxygenation without therapeutic anticoagulation in adults: a systematic review of the current literature. Int J Artif Organs2020. Epub ahead of print 10 February 2020. DOI: 10.1177/0391398820904372.
32037946
27.
ZhouF.YuT.DuRet al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet2020; 395: 1054–1062.doi:10.1016/S0140-6736(20)30566-3http://www.ncbi.nlm.nih.gov/pubmed/32171076
28.
HenryBM.LippiG. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports. J Crit Care2020; 58: 27–28.doi:10.1016/j.jcrc.2020.03.011http://www.ncbi.nlm.nih.gov/pubmed/32279018
29.
ChowJ.AlhussainiA.Calvillo-ArgüellesOet al. Cardiovascular collapse in COVID-19 infection: the role of veno-arterial extracorporeal membrane oxygenation (VA-ECMO). CJC Open2020. Epub ahead of print 08 Apr 2020. DOI: 10.1016/j.cjco.2020.04.003.
http://www.ncbi.nlm.nih.gov/pubmed/32363334
30.
JacobsJP.StammersAH.St LouisJet al. Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in COVID-19: experience with 32 patients. ASAIO J2020. Epub ahead of print 17 Apr 2020. DOI: 10.1097/MAT.0000000000001185.
32317557
KowalewskiM.FinaD.SłomkaAet al. COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review. Crit Care2020; 24: 205.doi:10.1186/s13054-020-02925-3http://www.ncbi.nlm.nih.gov/pubmed/32384917
34.
ZochiosV.BrodieD.CharlesworthMet al. Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?Anaesthesia2020. Epub ahead of print 22 Apr 2020. DOI: 10.1111/anae.15099.
http://www.ncbi.nlm.nih.gov/pubmed/32319081